LONDON–(BUSINESS WIRE) – OMRON Healthcare Co., Ltd. (Headquarters: Muko City, Kyoto, Japan, President and CEO: Isao Ogino) and Kyoto University (Sakyo-ku, Kyoto City, Kyoto, Japan, President: Nagahiro Minato) today announced a new collaborative research program called “Healthcare Medical AI “(Principal Researcher: Yasushi Okuno, Ph.D., Prof., Department of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University) on the use of artificial intelligence (AI) and an innovative data set of home measurements for the prevention of cardiac Circulatory diseases.
The Collaborative Research Center’s first study examines how AI can derive new personalized methods for improving blood pressure based on both day and night blood pressure fluctuations, home EKG recordings, and lifestyle data. The aim is to further improve high blood pressure management. The study aims to investigate how AI can accurately predict cardiovascular diseases at an early stage.
High blood pressure is the leading cause of death worldwide * 1. Since cardiovascular diseases often result in the need for care, it is important to prevent events not only from the point of view of the risk to life, but also with a view to maintaining the quality of life. In Japan, around 43 million * 2 people have high blood pressure, 29% of whom have been treated and their blood pressure levels have been poorly controlled * 3. In order to prevent life-threatening events, further solutions for patients with high blood pressure need to be developed. Even when blood pressure readings are properly controlled, there is still an opportunity for patients to develop an event. Therefore, early detection and intervention in hypertension care should be emphasized so that events can be predicted during daily health management.
The collaboration between Kyoto University and OMRON Healthcare focuses on two research topics: The development of a novel blood pressure management method and blood pressure analysis for the early detection of cardiovascular events using AI. Regarding the novel blood pressure management method, the joint team will use AI technology to develop personalized blood pressure management by using biological records (body weight, body composition, activity volume and Na / K ratio * 4) and habits (smoking and drinking) on a daily basis. The team will develop a system for detecting abnormal home readings of symptoms of cardiovascular events at an early stage. Since events occur unpredictably, the early detection of the disease is one of the central challenges. By analyzing changes in various biological data sets measured at home using AI technology, signs of events can be identified faster and more likely, so that treatment can be adjusted and cardiovascular events prevented.
“OMRON’s Going for Zero mission is big and brave, and we cannot do it alone. This collaboration with Kyoto University to develop groundbreaking new research on Al and cardiovascular disease is another example of how we are working with like-minded organizations to improve outcomes and make measurable progress in heart attack and stroke eradication, ” said Ranndy Kellogg.
“Collaboration is an essential, albeit underused, instrument that opens completely new doors and ultimately makes patients healthier. Our partnership with Kyoto University is an exciting example of this, combining the legacy and richness of OMRON Healthcare’s cardiovascular experience with the university’s expertise in applied AI research for health data. Through joint initiatives like these, we can move the healthcare industry forward, ”added Andre Van Gils, OMRON Healthcare’s Senior General Manager Global Sales & Marketing. “Our latest flagship program, Hypertension Plus, with the NHS in the UK and VitalSight in North America, demonstrates the feasibility and applicability of remote patient monitoring in day-to-day practice. This research program with Kyoto University could stratify such programs and enable a new generation of highly personalized preventive care. ”
OMRON Healthcare is known worldwide for its Going for Zero mission to eliminate heart attacks and strokes. Over the past six years, the company has expanded its business from blood pressure measurement to innovative devices such as a portable blood pressure monitor and health management services. In the US, UK and Singapore, OMRON has launched new remote patient monitoring services that measure biological records from the home and share the data with healthcare professionals to give them better insight into the health of their patients and the treatment they need required plans and contributes to the Going for Zero mission.
The program will undoubtedly help us continue the vision of Going for Zero to Eliminate Cardiovascular Disease through OMRON’s vital sensor technology with the help of Kyoto University’s AI.
References:
*1. GBD 2019 Risk Factors Collaborators, vol. 396, 10258, P1223-1249, 2020.doi.org/10.1016/S0140-6736(20)30752-2
* 2. Comprehensive survey of living conditions in 2013
* 3. Guidelines for the Treatment of Hypertension in 2019
* 4. The sodium: potassium (Na +: K +) ratio in the urine
Yasushi Okuno, Ph.D., Prof., Department of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
In the midst of the global pandemic of COVID-19 and the increasing threat of health systems collapse, one of the most pressing challenges is the development of medical systems outside of hospitals. This is directly related to the problems we will face in the near future, such as the escalation of medical costs due to the aging society and the decline in health workforce. In this Collaborative Research Center “Healthcare Medical AI”, we would like to work with a new type of health system and AI studies to research solutions to how the risk of events can be avoided and how one can live happier and healthier at home.
Takehiro Hamaguchi, Senior General Manager of Technology Development HQ, OMRON Healthcare Co., Ltd.
OMRON Healthcare’s accumulated worldwide sales of home blood pressure monitors have reached 300 million units and are now available to people around the world. At the same time, however, there are still many people struggling with high blood pressure treatment who have suffered from serious medical conditions. We have launched the joint research program “Healthcare Medical AI” with the University of Kyoto and will examine the relationship between personal characteristics, lifestyle and high blood pressure and then, based on the findings, discover effective ways to improve the condition. In addition, we will try to find out the most effective system for preventing cardiovascular events with our innovative biosensors and AI.
Structure of the Collaborative Research Center “Healthcare Medical AI”
-
Program Name: Healthcare Medical AI
-
Venue: On the Kyoto University campus
-
Period: From June 2021 to March 2024
source https://dailyhealthynews.ca/omron-healthcare-and-kyoto-university-collaborative-research-program-healthcare-medical-ai-to-prevent-the-events-of-cardiovascular-diseases-with-ai-and-home-measurement-data/
No comments:
Post a Comment